INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 47m ago
HOUSE PTR6m ago
SEC 13F6m ago
ROBINHOOD CHAIN6m ago
SEC FORM 4/Grant or awardVerified data

Lillie Charisse R reported EXC

Director · EXELON CORP · EXELON CORP — Deferred phantom share equivalents

Side
A
Value
$233
Shares
5
Price
$46.62
Executed
Jun 30, 2026
Disclosed
Jul 1, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jun 30 executedJul 1, 2026 disclosed

EXC · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

$233 reported value · 0.1% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · EXC

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    LR
    Lillie Charisse RDirector
    EXCEXELON CORP
    Grant or award
    		A$242
    6 sh
    		Sep 30, 2026Oct 1, 2026
    traded Sep 30, 2026
    		+1dSEC FORM 4

    Evidence

    21
    RC
    Rogers Matthew CDirector
    EXCEXELON CORP
    Grant or award
    		A$36K
    897 sh
    		Sep 30, 2026Oct 1, 2026
    traded Sep 30, 2026
    		+1dSEC FORM 4

    Evidence

    21
    RC
    Rogers Matthew CDirector
    EXCEXELON CORP
    Grant or award
    		A$36K
    778 sh
    		Jun 30, 2026Jul 1, 2026
    traded Jun 30, 2026
    		+1dSEC FORM 4

    Evidence

    9
    LR
    Lillie Charisse RDirector
    EXCEXELON CORP
    Grant or award
    		A—
    3,720 sh
    		Apr 28, 2026Apr 29, 2026
    traded Apr 28, 2026
    		+1dSEC FORM 4

    Evidence

    9
    SK
    Segedi Bryan KDirector
    EXCEXELON CORP
    Grant or award
    		A—
    3,720 sh
    		Apr 28, 2026Apr 29, 2026
    traded Apr 28, 2026
    		+1dSEC FORM 4

    Evidence

    9
    RC
    Rogers Matthew CDirector
    EXCEXELON CORP
    Grant or award
    		A—
    3,720 sh
    		Apr 28, 2026Apr 29, 2026
    traded Apr 28, 2026
    		+1dSEC FORM 4

    Evidence

    13
    RC
    Rogers Matthew CDirector
    EXCEXELON CORP
    Grant or award
    		A$44K
    878 sh
    		Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    		+1dSEC FORM 4

    Evidence

    9
    RC
    Rogers Matthew CDirector
    EXCEXELON CORP
    Grant or award
    		A$36K
    739 sh
    		Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    		+1dSEC FORM 4

    Evidence

    13
    SK
    Segedi Bryan KDirector
    EXCEXELON CORP
    Grant or award
    		A$44K
    878 sh
    		Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    		+1dSEC FORM 4

    Evidence

    9
    LR
    Lillie Charisse RDirector
    EXCEXELON CORP
    Grant or award
    		A$245
    5 sh
    		Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    		+1dSEC FORM 4

    Evidence

    13
    LR
    Lillie Charisse RDirector
    EXCEXELON CORP
    Grant or award
    		A$44K
    878 sh
    		Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    		+1dSEC FORM 4

    Evidence

    9
    KA
    Kleczynski Robert ASVP, Controller & Tax
    EXCEXELON CORP
    Grant or award
    		A—
    5,673 sh
    		Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    		+2dSEC FORM 4

    Evidence

    9
    KA
    Kleczynski Robert ASVP, Controller & Tax
    EXCEXELON CORP
    Grant or award
    		A—
    7,019 sh
    		Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    		+2dSEC FORM 4

    Evidence

    9
    KA
    Kleczynski Robert ASVP, Controller & Tax
    EXCEXELON CORP
    Option exercise
    		M—
    7,019 sh
    		Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    		+2dSEC FORM 4

    Evidence

    13
    JM
    Jones Jeanne MEVP, CFO, Audit & Risk
    EXCEXELON CORP
    Option exercise
    		M—
    5,197 sh
    		Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    		+2dSEC FORM 4

    Evidence

    13
    JM
    Jones Jeanne MEVP, CFO, Audit & Risk
    EXCEXELON CORP
    Option exercise
    		M—
    6,485 sh
    		Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    		+2dSEC FORM 4

    Evidence

    13
    JM
    Jones Jeanne MEVP, CFO, Audit & Risk
    EXCEXELON CORP
    Option exercise
    		M—
    7,031 sh
    		Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    		+2dSEC FORM 4

    Evidence

    17
    JM
    Jones Jeanne MEVP, CFO, Audit & Risk
    EXCEXELON CORP
    Option exercise
    		M—
    24.7K sh
    		Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    		+2dSEC FORM 4

    Evidence

    23
    JM
    Jones Jeanne MEVP, CFO, Audit & Risk
    EXCEXELON CORP
    Tax withholding
    		F$705K
    16.1K sh
    		Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    		+2dSEC FORM 4

    Evidence

    19
    JM
    Jones Jeanne MEVP, CFO, Audit & Risk
    EXCEXELON CORP
    Disposition to issuer
    		D$314K
    7,154 sh
    		Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001972789-26-000008
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jun 30, 2026
    Published
    Jul 1, 2026
    Ingested by INSIDER
    Nov 5, 03:50 UTC
    Last re-read
    Nov 5, 03:50 UTC

    Extracted facts

    Filer
    Lillie Charisse R
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    EXELON CORP — Deferred phantom share equivalents
    Ticker
    EXC
    Shares
    5
    Price per share
    $46.62
    Value
    $233
    Execution date (reported)
    Jun 30, 2026
    Owned after transaction
    3,896 shares
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 5
    • Price: $46.62

    = $233

    What this establishes

    Lillie Charisse R filed this Form 4 reporting a grant or award of EXC on Jun 30, 2026. It became public on Jul 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Lillie Charisse Rcik:0001972789
    Issuer
    EXELON CORPcik:0001109357

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.